Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.
Also called NCT04484259
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 105 participants
- Sponsor
- Registry
-
NCT04484259
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04484259. Randomized; no masking; primary purpose treatment. Start 2021-03-31 (actual); primary completion 2024-01-29 (actual). Results posted on 2025-03-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
- Acronym
- OPTIMUS-7
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Ticagrelor monotherapy
- Intervention (Drug)
- Ticagrelor plus aspirin
- Intervention (Drug)
- Clopidogrel with aspirin
- Lead sponsor
- University of Florida
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct04484259- Content hash
d1bb6d27d6aaad8789c738b55a12b738e0733eb992fc96a474e7e8c82ecc5d67